Tag Archives: John Santilli

Key Trends in Healthcare for 2020 and Beyond

Transparency has been elevated as consumerism marches forward in the face of steadily increasing healthcare costs

Key Strategic Trends that Impact Healthcare Decision-Making and Stakeholder Roles in the New Marketplace

By John Santilli, MBA, and F. Randy Vogenberg, PhD, RPh After the passage of the Affordable Care Act (ACA) in 2010, market changes beyond those already in play began to emerge. Traditional roles, responsibilities, and authority could now be tested or altered as a result of some sections of the ACA. One result is that […]

John Santilli quoted in Modern Medicine: Ebola clinical activity heats up with vaccine candidates in works

Ebola is unlikely to become a profitable endeavor for Western pharmaceutical companies, “affecting primarily the poor in Africa with demand for drugs relatively modest,” according to John Santilli, of Access Market Intelligence, which provides market intelligence to the pharmaceutical and healthcare industries. http://formularyjournal.modernmedicine.com/formulary-journal/news/ebola-clinical-activity-speeds-vaccine-candidates-works

John Santilli quoted in Modern Medicine: Top Five Industry Challenges of 2015

Employers and insurers are responding to costs of expensive drugs like Sovaldi with step therapy, or higher tiers of drug-payment categories, and shifting the site of care from hospitals to physician offices, says John Santilli, partner in Access Market Intelligence. Read more here: http://managedhealthcareexecutive.modernmedicine.com/managed-healthcare-executive/news/top-five-industry-challenges-2015?page=0,7

John Santilli quoted in Modern Medicine: Olysio indication expanded for combo use with Sovaldi in hepatitis C

“[Hepatitis C] is a very competitive market, as a number of companies are looking to compete with Gilead’s products due to the large population of patients and the high earnings potential for drug sales,” said John Santilli, of Access Market Intelligence, which provides market intelligence to the pharmaceutical and healthcare industries.  Read more here: http://managedhealthcareexecutive.modernmedicine.com/managed-healthcare-executive/news/top-five-industry-challenges-2015?page=0,7

Budget Time: Remember to include us in your 2015 budget

It’s that time of year again – budget time! As the days get shorter and the temperatures cooler, it’s time to remember the important tools that help keep business in the black: marketing your hot new products and budgets. To make the most of these new products and services, you’ll need to stay on top of […]

Trends: Big Brands Reducing Negative Impact

Consumers are paying attention.  From Goodwill’s obnoxiously low pay for disabled workers to the latest smoke-and-mirrors shuffling from quantitative easing, consumers are watching brands and businesses far more closely than in recent years for unethical policies and practices. In response, businesses are becoming much more proactive in reducing negative impacts to their brand, because they […]

Genentech Distribution Decision

This is an example of a pharmaceutical company helping another group of healthcare stakeholders, health plans, because of an issue with health systems increasing cost of care. Stakeholders in the healthcare market, while working to reduce the cost of care, are trying to determine the best path to profitability. An example is Genentech’s decision to […]